For other salt forms please inquire. Inhibitor of protein kinase G I α and I β. Resistant against mammalian cyclic nucleotide-dependent phosphodiesterases, no metabolic side effects. Significantly more lipophilic and membrane-permeant compared to cyclic GMP or Rp-cGMPS. Detailed technical information and updated reference list available on request. Reference: Zhuo et al., Nature 368, 635 - 639 (1994).
Cat. No. | B 005 |
CAS number | [150418-07-8] |
Purity | > 99% HPLC |
Salt form | Sodium |
Storage temperature | -20°C / -4°F |
Molecular formula | C₁₀H₁₀BrN₅O₆PS · Na |
Molecular weight [g/mol] | 462.2 |
Modifications | 8-cGMP |
Target | PKG (cGK) Inhibitor |
Lipophilicity | 1.29 |
Absorption max [nm] | 260 |
Molar extinction coefficient ε [L·mol⁻¹·cm⁻¹] | 16200 |